期刊文献+

脂肪酸氧化代谢病与心肌病 被引量:1

Fatty acid oxidation disorders and cardiomyopathy
原文传递
导出
摘要 脂肪酸是心肌最重要的能量来源,脂肪酸氧化代谢病(FAOD)可导致线粒体能量生成不足,同时可造成心肌细胞内脂质和长链酰基肉碱等中间代谢产物蓄积,从而导致心肌病变。FAOD主要包括肉碱依赖的脂肪酸转运障碍和线粒体内的脂肪酸β-氧化异常,缺陷可发生于脂肪酸氧化过程中的任何酶或转运蛋白。尽管FAOD是引起儿童心肌病的少见病因之一,但部分FAOD通过早期纠正脂肪酸代谢紊乱后,心肌病有望得到改善,生存质量可显著提高。 myocardium. Fatty acid oxidation disorders(FAODs)can give rise to insufficiency of mitochondrial energy production and accumulation of metabolic intermediates in cardiomyocytes,such as lipid and long-chain acyl carnitine,leading to myocardial lesions.FAODs include carnitine-dependent fatty acid transport disorders and mitochondrial fatty acid beta-oxidation disorders,with any enzyme or transporter defect in fatty acid oxidation process resulting in this disease. Although FAODs are one of the rare causes of pediatric cardiomyopathy,some patients with FAODs are expected to have cardiomyopathy alleviated and quality of life improved by early correction of fatty acid metabolic disorders.
作者 傅立军 陈浩 FU Li-jun;CHEN Hao(Department of Cardiology,Shanghai Children's Medical Center,Shanghai Jiao Tong University School of Medicine,Shanghai 200127,China)
出处 《中国实用儿科杂志》 CSCD 北大核心 2019年第1期29-32,共4页 Chinese Journal of Practical Pediatrics
关键词 脂肪酸氧化代谢病 心肌病 fatty acid oxidation disorders cardiomyopathy
  • 相关文献

参考文献2

二级参考文献19

  • 1傅立军,窦薇,周爱卿,黄美蓉,杨健萍,李奋.糖原累积病Ⅱ型的临床分析和基因学检测[J].临床儿科杂志,2006,24(12):962-965. 被引量:12
  • 2Pierpont ME, Breningstall GN, Stanley CA, et al. Familial carnitine transporter defect : A treatable cause of cardiomyopathy in children. Am Heart J, 2000, 139:S96-S106.
  • 3Penersen MD, Du W, Skeens ME, et al. Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents : an echocardiographic study. J Am Soc Echocardiogr, 2008, 21 : 922-934.
  • 4Longo N, Amat di San Filippo C, Pasquali M. Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet, 2006, 142C : 77-85.
  • 5Tripp ME, Katcher ML, Peters HA, et al. Systemic carnitine deficiency presenting as familial endocardial fibroelastosis. N Engl J Med, 1981, 305 : 385-390.
  • 6Waber LJ, Valle D, Nei11 C, et al. Carnitine deficiency presenting as familial cardiomyopathy: A treatable defect in carnitine transport. J Pediat, 1982, 101:700-705.
  • 7Matsuishi T, Hirata K, Terasawa K, et al. Successful carnitine treatment in two siblings having lipid storage myopathy with hypertrophic cardiomyopathy. Neuropediatrics, 1985, 16 : 6-12.
  • 8Tein I, De Vivo DC, Bierman F, et al. Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood camitine-responsive cardiomyopathy. Pediatr Res, 1990, 28: 247-255.
  • 9Ferro F, Ouille A, Tran TA, et al. Long-chain acylcarnitines regulate the HERG channel. PLoS One, 2012, 7: e41686.
  • 10Stanley CA, DeLeeuw S, Coates PM, et al. Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake. Ann Neurol, 1991, 30: 709-716.

共引文献13

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部